How many studies have been conducted on Sb203580?

BiohacksAI has indexed 106 PubMed studies on Sb203580, including 1 randomized controlled trials (RCTs). 14% of studies involve human subjects.

What are the main research areas for Sb203580?

The primary research domains for Sb203580 are 🔬 Oncology, 🔬 Inflammation, 🦴 Bone & Joint. This is based on analysis of 106 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Sb203580

A 38-kDa mitogen-activated protein kinase that is abundantly expressed in a broad variety of cell types. It is involved in the regulation of cellular stress responses as well as the control of proliferation and survival of many cell types. The kinase activity of the enzyme is inhibited by the pyridinyl-imidazole compound SB 203580.

106+ PubMed studies analyzed · 1 RCTs · Evidence Score: 44.5

Research Domains

Sb203580 has been studied across 20 research domains including 🔬 Oncology, 🔬 Inflammation, 🦴 Bone & Joint, 🛡️ Immunity, ❤️ Cardiovascular. The primary research focus is 🔬 Oncology with 38% of studies addressing this area.

Loading evidence profile...

This evidence profile for Sb203580 is generated deterministically from 106 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.